After performance data showed 95% sensitivity and specificity, the FDA authorized the assay’s marketing in the United States for detection of HIV-1 drug-resistant mutations.
For the FLU-IVIG trial, researchers evaluated the safety and efficacy of anti-influenza hyperimmune intravenous immunoglobulin to better understand the clinical benefits for patients with influenza.
In a new study, the researchers aimed to compare antibody titers to HPV with the rate of abnormal cytology between perinatally HIV-infected and perinatally HIV-exposed, uninfected youth.
Tuberculosis is common among patients with HIV. Therefore, the authors of a new study set out to find a point-of-care test that can screen for TB quickly and accurately.
While it is known that disease progression of HIV-1 is delayed by HIV-2 in coinfected individuals, authors of a new study sought to identify the protective mechanisms of the coinfection.
To better understand immune reconstitution in children with HIV taking antiretroviral therapy, researchers compared immune activation, immune exhaustion, and HIV- and copathogen-specific T-cell responses in...
After 2 randomized clinical trials found it as safe and effective as the standard 3-drug regimen, the FDA approved the first 2-drug regimen for adults with HIV-1 who have never been treated with ART.
While neurocognition can increasingly decline with age among individuals with HIV, researchers of a study presented at CROI 2019 determined which factors are connected with neurocognitive decline in the...
As effective HIV interventions have been identified, the design and interpretation of HIV prevention trials has evolved. David Dunn, from University College London, explained these changes during CROI...
